PEBP1 and lung adenocarcinoma: Li et al. [28] indicated the miR-27a was up-regulated in lung adenocarcinoma patients treated with cisplatin-based chemotherapy and confirmed that it might be associated with low expression of RKIP, decreased sensitivity to cisplatin, and poor prognosis.